土耳其央行：通胀预期和定价行为持续对通胀回落进程构成风险。 ...

Core Insights - The president of Qifu Technology, Zhou Xuqiang, emphasized the importance of achieving broader coverage of inclusive customer groups, more precise risk pricing, and more flexible business growth as key strategies to address industry homogenization and stimulate consumer potential [1] Company Highlights - Qifu Technology showcased the significant intelligent modules of the Qifu Credit Super Intelligent Agent at the 2025 China International Financial Expo [1] - The Qifu Credit Super Intelligent Agent aims to match expert-level credit capabilities for banks, assisting them in enhancing both technological and business strengths [1]

其中，杭序府首开价59098元/㎡，比此前板块限价涨7098元/㎡；岸芷丁香清盘加推迎来第三次涨价，三开均价59348元/㎡。加上首开均价65600元/㎡的锦上 万象府，三大总价千万元级别的改善新盘"同台竞技"，考验着不限价后杭州中高端市场的购买力。 钱二首个不限价盘入市 首开均价59098元/㎡ 杭序府位于钱江新城二期东侧，距离地铁9号线红普南路站约300多米，往南不远是交付不久的天澜海岸、天澜美境，北侧一路之隔是刚售罄的限价盘潮语映 月轩。 杭序府效果图 去年12月31日，招商以楼面价37629元/㎡竞得四堡七堡单元JG1405-27地块。该楼盘是杭州计容新规后出让的地块，规划设计成全架空平台，整个小区往上 抬升，地库设置在地上一层。此前余杭五常的时舟里、钱塘下沙的沐兰台都采用了架空平台设计，杭序府则是杭州主城首个全架空设计的项目。 潮新闻客户端 记者 武恒光 继城东新城的锦上万象府领证后，杭州主城区又有两个改善新盘同期进场：钱江新城二期首个不限价新盘杭序府于昨晚首开领证，另外，最早入市的东新单 元岸芷丁香也迎来清盘加推。 对于杭序府的首开价，市场接受度如何还有待验证。事实上，该项目所处的钱江新城二期东区 ...

近期，可转债市场迎来评级调整密集期。 受业绩亏损、债务压力及行业政策冲击等多重因素影响，百畅转债、闻泰转债、普利转债等十余只可转债相继遭遇评级下调，引发市场对相关可转债信用风险的关 注。 业内人士指出，尽管当前可转债退市风险整体可控，但行业分化加剧与评级下调的"季节性规律"仍需警惕。 百畅转债等遭遇评级下调 6月18日，百川畅银发布公告称，公司近日收到中证鹏元资信评估股份有限公司（简称"中证鹏元"）出具的《2023年河南百川畅银环保能源股份有限公司向不特定 对象发行可转换公司债券2025年跟踪评级报告》，中证鹏元将公司主体信用等级由"A+"调整为"A"，百畅转债评级由"A+"调整为"A"，评级展望为稳定。 中证鹏元表示，本次评级下调主要是基于公司2024年业绩亏损加剧和2025年一季度连续亏损，沼气发电业务面临项目可开发机会减少、填埋气不足、垃圾焚烧发 电替代、资产损失减值加大等风险，并需关注沼气发电上网电价补贴政策变动及公司的补贴款存在不能及时回收的风险；公司拟通过布局移动储能供热业务补亏， 但该业务的规模化拓展受制于资金压力，快速规模化发展尚需时间。此外，公司流动性风险高企，现金资产无法覆盖短期债务，短期 ...

油价探底回升，SC原油期货站稳550关口，机构分析表示，中长期来看，原油走势将回归基本面定价的 逻辑，宏观层面及原油供需情况仍会对油价形成压力，使油价重心下行。 相关链接 期货热点追踪 ...

Core Points - The National Healthcare Security Administration (NHSA) has released a guideline for the pricing of cosmetic surgery services, aiming to standardize and regulate the pricing of cosmetic procedures [1][2] - The guideline includes 101 cosmetic surgery projects, such as injection fees, rhinoplasty fees, and fat transfer fees, with a focus on clear and understandable naming conventions for services [1][3] - The guideline introduces a policy for additional charges for revision surgeries, recognizing the increased technical demands and time required for such procedures [2] Group 1 - The guideline standardizes the naming of cosmetic surgery services, making it easier for patients to understand the procedures and associated costs [1][3] - It includes new pricing projects for "reduction tension suturing" and "incision cosmetic modification," encouraging medical institutions to minimize scar formation through advanced techniques [3] - Most of the cosmetic procedures outlined in the guideline are not covered by health insurance and are considered out-of-pocket expenses, allowing medical institutions to set their own pricing [3] Group 2 - The guideline addresses the issue of varying quality among medical institutions in the cosmetic surgery field, which can lead to unsatisfactory results for patients [2] - It emphasizes the importance of transparency and fairness in pricing, encouraging institutions to publicly disclose their pricing structures [3] - The NHSA aims to guide provincial healthcare authorities to adopt the guidelines and assist qualified medical institutions in setting reasonable prices based on quality and service [3]

Core Viewpoint - The ongoing dispute between Changchun Shengboma and New Oxygen Youth Clinic highlights the complexities of compliance and pricing mechanisms in the domestic medical beauty filler market, specifically regarding the product "Aivilan" [1][2] Group 1: Industry Dynamics - The traditional medical beauty market has seen supply-side dominance over pricing, where the cost of consumables, manufacturer profits, and channel premiums dictate the final price [2][5] - The pricing formula can be simplified as: Price = Consumable Cost + Manufacturer Profit + Channel Premium [2] - Manufacturers retain over 90% gross profit margins, leaving minimal profit for other channels and institutions [5][10] Group 2: Pricing Mechanisms - The pricing structure involves multiple layers of markup from manufacturers to distributors and ultimately to medical institutions, leading to significant price inflation [5][6] - For example, the market price of Juvederm Ultra 4 in South Korea is around 2000 RMB, while in first-tier Chinese cities, it can exceed 6000 RMB due to various markups [5][10] - Manufacturers employ various strategies to maintain price control, including supply adjustments, legal pressure on price-cutting distributors, and limiting access to authenticity verification channels [6][10] Group 3: Consumer Perspectives - Consumers often oppose the manufacturers' pricing logic, advocating for transparency and market-driven pricing rather than excessive premiums [2][15] - The dichotomy between the medical attributes of beauty services and their consumer aspects reflects a fundamental conflict in the industry [2][14] - The current pricing logic tends to overlook the value of medical services, leading to a focus on cost-cutting rather than enhancing consumer experience [10][12] Group 4: Future Considerations - A potential solution to the pricing dilemma is itemized pricing, which would reflect the comprehensive service experience rather than just the cost of consumables [11][13] - The industry should aim for a pricing model that allows for fair profit margins for manufacturers while ensuring quality service and safety for consumers [13][14] - Ultimately, the question of who determines medical beauty service prices should involve multiple stakeholders, reflecting a consensus rather than unilateral control [14][16]

24.06.28 《国债期货跨期价差系列专题一： 理论定价与影响因子》 研究通讯 2025 年 6 月 18 日星期三 当前国债期货跨期价差定价特征与展望 摘要： 本轮 2506-2509 合约跨期价差总体处于负值运行，从 5 月走势来看， 不同品种之间有所分化：TL 和 T 合约走势波动下行，且 TL 合约跨期价 差（连续）出现了上市以来的新低；TF 与 TS 合约则呈现先下行后上行 再下行的复杂走势。本文从国债期货定价的角度拆解本轮跨期价差运行 的内在逻辑，分析当前国债期货跨期价差定价的特点，并展望新一轮跨期 价差（2509-2512）的变化。 研究通讯 投资咨询业务资格： 证监许可【2011】1292 号 联系信息 熊睿健 投资咨询资格：Z0019608 电话：020-88818020 邮箱：xiongruijian@gf.com.cn 相关报告 23.07.11 《国债期货交割历史回顾之：交割 券的选择》 24.08.28 《国债期货跨期价差系列专题二： 多因子量化套利策略》 24.12.20 《国债期货跨期价差系列专题三： 基于跨期价差预测信号的移仓优化策略》 本报告中所有观点仅供参考，请务必阅读正 ...

Core Viewpoint - New Oxygen (SY.O), known as the "first stock in internet medical beauty," is transitioning to offline institutions, having opened 23 self-operated medical beauty institutions across 9 cities in China within two years since May 2023 [1] Group 1: Business Expansion - In Q1 2025, New Oxygen's medical beauty chain business revenue reached 99 million yuan, a year-on-year increase of over 500% [1] - Management expects the revenue for this business in Q2 to be between 120 million and 140 million yuan [1] Group 2: Conflict with Suppliers - Tensions are rising between New Oxygen and upstream medical beauty material companies, particularly regarding the compliance issues of the "Aivilan" product used in New Oxygen's self-operated clinics [2] - The supplier, Changchun Shengboma Biological Materials Co., claims it does not guarantee the authenticity of the products sold by New Oxygen and has not trained their medical staff on the product [2][3] Group 3: Pricing Strategy - New Oxygen's pricing strategy involves selling a combination product called "Miracle Youth," which includes Aivilan and is priced at 5,999 yuan, significantly lower than the standard price of around 18,000 yuan for Aivilan alone [6][7] - This pricing strategy has raised concerns about whether the use of Aivilan for purposes beyond its approved indications constitutes off-label use [8] Group 4: Industry Dynamics - The conflict reflects broader issues in the medical beauty industry, where upstream manufacturers are losing pricing power amid fierce competition and price wars [10][11] - New Oxygen argues that its pricing strategy is a necessary correction to an unreasonable profit structure in the industry, aiming to make medical beauty services more accessible to a wider audience [13]

以下文章来源于远川研究所 ，作者罗雪妍 远川研究所 . 去年高考季，张雪峰直播间发布11999元/17999元 两档 高考志愿填报服务，2万个名额被一抢而空，给江湖留下"3小时赚2亿"的传说。 今年高考前一周，张雪峰哽咽宣布"或将"停播，声泪俱下不知是为暂停"寒门救星"的使命而遗憾，还是痛惜到账金额少了一笔。但已知的是，上述两档服 务今年分别涨价1000元，上架20分钟后，大部分省份就售罄。 中国人的一生处处都是分水岭，但每一处分水岭在充分竞争的市场有不同的定价。按照研究机构的测算，志愿填报这一分水岭，市场规模就在过去十年翻 了十倍。 未成年人或许还不懂"同分不同命"的残酷现实，但他们的父母大概都对"选择比努力更重要"这句话感触深刻。 复杂的规则、善变的环境、性价比的权衡叠加在一起，高考志愿填报成为一场比高考更复杂的较量。 被放大的焦虑 过去十年，高考的难度未必增加，但志愿填报的复杂性却与日俱增。 刻画这个时代 高考门前是非多。 文 ｜ 罗雪妍 编辑 ｜ 李墨天 来源｜ 远川研究所（ID： YuanChuanInstitution ） 封面来源 ｜ 视觉中国 菜单上有270个菜都足以让人头皮发麻，更不用说填志 ...